Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Still a Buy?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up prior to trading on Monday . The stock had previously closed at $3.41, but opened at $10.22. Curaleaf shares last traded at $9.9125, with a volume of 47,784 shares trading hands.

Wall Street Analyst Weigh In

Separately, Zacks Research cut shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Buy”.

Curaleaf Trading Up 186.5%

The business’s 50-day simple moving average is $7.64 and its 200-day simple moving average is $7.58. The company has a market capitalization of $6.83 billion, a price-to-earnings ratio of -75.15 and a beta of 1.53. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.51. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The business had revenue of $324.23 million for the quarter, compared to analyst estimates of $316.62 million. On average, research analysts expect that Curaleaf Holdings, Inc. will post -0.1 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.